Extended supplementation with Bacillus coagulans BCP92 showed no major alterations but subtle beneficial changes in gut microbiome composition and a slight increase in short-chain fatty acids in healthy subjects.
Bacillus coagulans BCP92 supplementation produced no major alterations in gut microbiome composition in healthy participants over 42 days.
Subtle beneficial changes in microbiota composition were observed in the treatment group receiving B. coagulans BCP92.
A slight increase in short-chain fatty acids (SCFAs) was observed in fecal samples of participants receiving B. coagulans BCP92.
The study evaluated both safety and efficacy of B. coagulans BCP92 in healthy subjects, a population rarely investigated in probiotic research.
The authors conclude that extended supplementation with B. coagulans BCP92 may lead to substantial improvements in gut microbiome composition and SCFA levels.
This research suggests that taking a probiotic supplement called Bacillus coagulans BCP92 (at a dose of 1 billion colony-forming units per day) for 42 days does not dramatically change the gut bacteria community in healthy people, but may produce small beneficial shifts. The study, which involved 48 healthy adults randomly assigned to take either the probiotic or a placebo (an inactive sugar-based capsule), found that the probiotic group showed subtle increases in beneficial types of bacteria and slight decreases in potentially harmful ones. There was also a modest increase in short-chain fatty acids — compounds produced by gut bacteria that are associated with digestive and overall health — in the stool samples of those taking the probiotic. This research matters because most studies on probiotics focus on people who are already sick or have gut imbalances. This trial specifically looked at healthy people, which is a less commonly studied group. The findings suggest that even in a healthy gut, this particular probiotic strain may nudge the microbial community in a favorable direction without causing harm. The authors note that the changes observed were small after 42 days, and they suggest that longer periods of supplementation might produce more meaningful improvements. In practical terms, this research suggests that B. coagulans BCP92 appears safe for healthy adults and may offer modest benefits to gut health over a 6-week period. The findings also point to a need for longer trials to better understand how sustained probiotic use might affect gut bacteria and their byproducts in people who are already healthy.
Upload your bloodwork. We'll cross-reference your results against this study and 4,700 others.
Upload Your LabsShaikh S, Malek F. (2026). Healthy subjects gut microbiome modulation by Bacillus coagulans BCP92: A randomized, double-blind, placebo-controlled clinical trial.. Medicine. https://doi.org/10.1097/MD.0000000000050435